Literature DB >> 6300418

Molecular cloning of viral DNA from leukemogenic Gross passage A murine leukemia virus and nucleotide sequence of its long terminal repeat.

R Villemur, E Rassart, L DesGroseillers, P Jolicoeur.   

Abstract

The viral DNA genome of the leukemogenic Gross passage A virus was cloned in phage Charon 21A as an infectious molecule. The virus recovered by transfection with this infectious DNA was ecotropic, N-tropic, fibrotropic, and XC+. It was leukemogenic when reinjected into newborn SIM mice, indicating that ecotropic murine leukemia virus (MuLV) from an AKR mouse thymoma can harbor leukemogenic sequences. Its restriction map was similar to that of nonleukemogenic AKR MuLV, its putative parent, but differed at the 3' end and in the long terminal repeat (LTR). The nucleotide sequence of the Gross A virus LTR was identical to the AKR MuLV LTR sequence (Van Beveren et al., J. Virol. 41:542-556, 1982) in U5, R, and part of U3. All differences between both LTRs were found in U3. Only one copy of the U3 tandem direct repeat was conserved in the Gross A virus LTR, and it was rearranged by the insertion of a 36-base-pair sequence and by five point mutations. Only one additional point mutation common to several oncogenic MuLVs was present in U3. These structural changes in the U3 LTR and at the 3' end of the genome may be related to the leukemogenicity of this virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300418      PMCID: PMC256447     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Development and serial cellfree passage of a highly potent strain of mouse leukemia virus.

Authors:  L GROSS
Journal:  Proc Soc Exp Biol Med       Date:  1957-04

2.  Pathogenic properties, and "vertical" transmission of the mouse leukemia agent.

Authors:  L GROSS
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.

Authors:  C Van Beveren; E Rands; S K Chattopadhyay; D R Lowy; I M Verma
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Nucleotide sequences of the murine retrovirus Friend SFFVp long terminal repeats: identification of a structure with extensive dyad symmetry 5' to the TATA box.

Authors:  S P Clark; T W Mak
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Leukemogenesis by Gross passage A murine leukemia virus: expression of viruses with recombinant env genes in transformed cells.

Authors:  N G Famulari; C F Koehne; P V O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice.

Authors:  F S Pedersen; R L Crowther; E F Hays; R C Nowinski; W A Haseltine
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

9.  "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos.

Authors:  L GROSS
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

10.  Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice.

Authors:  W P Rowe; T Pincus
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

View more
  25 in total

1.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.

Authors:  H L Morrison; H Y Dai; F S Pedersen; J Lenz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.

Authors:  J Colicelli; S P Goff
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  A new family of LTR-like sequences abundantly expressed in rat tumors.

Authors:  N Suzuki; T Fujiyoshi; Y Maehara; K Takahashi; M Yamamoto; H Endo
Journal:  Nucleic Acids Res       Date:  1986-12-09       Impact factor: 16.971

5.  Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences.

Authors:  S Lovmand; N O Kjeldgaard; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

6.  Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design.

Authors:  E A Golemis; N A Speck; N Hopkins
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.

Authors:  M K Short; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  Nucleotide sequence of AKV murine leukemia virus.

Authors:  W Herr
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

9.  Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses.

Authors:  K Paludan; H Y Dai; M Duch; P Jørgensen; N O Kjeldgaard; F S Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Genesis of Kirsten murine sarcoma virus: sequence analysis reveals recombination points and potential leukaemogenic determinant on parental leukaemia virus genome.

Authors:  J D Norton; J Connor; R J Avery
Journal:  Nucleic Acids Res       Date:  1984-09-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.